Egerton Capital reported 23 stock positions worth $9.8B in its 2026 Q3 Form 13F, for the quarter ended Sep 30, 2026, filed Oct 20, 2026. Its largest position is VISA INC. (V), at 14.93% of the reported portfolio value. Its biggest move versus the previous quarter was in S&P Global Inc. (SPGI), where it increased the position by 124.6%.
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| V | VISA INC. | 14.93% | 4,079,226 | TRIMMED (-4.3%) |
| AMZN | AMAZON COM INC | 11.96% | 4,714,127 | ADDED (+31.9%) |
| APH | AMPHENOL CORP /DE/ | 9.19% | 10,708,713 | ADDED (+120.0%) |
| NVDA | NVIDIA CORP | 8.70% | 3,741,971 | ADDED (+9.5%) |
| MCO | MOODYS CORP /DE/ | 7.57% | 1,637,246 | TRIMMED (-3.9%) |
| GOOG | Alphabet Inc. | 7.28% | 2,099,142 | TRIMMED (-36.2%) |
| DVN | DEVON ENERGY CORP/DE | 5.08% | 10,829,392 | ADDED (+43.3%) |
| MDLN | Medline Inc. | 4.69% | 13,283,017 | TRIMMED (-19.4%) |
| SPGI | S&P Global Inc. | 3.17% | 790,364 | ADDED (+124.6%) |
| CRH | CRH PUBLIC LTD CO | 3.06% | 3,631,232 | TRIMMED (-17.2%) |
| IBKR | Interactive Brokers Group, Inc. | 2.75% | 3,160,704 | TRIMMED (-23.5%) |
| VMC | Vulcan Materials CO | 2.51% | 1,007,912 | TRIMMED (-48.9%) |
| EMBJ | EMBRAER S.A. · ADR | 2.49% | 3,242,138 | TRIMMED (-4.2%) |
| FERG | Ferguson Enterprises Inc. /DE/ | 2.40% | 1,060,203 | ADDED (+5.4%) |
| ICE | Intercontinental Exchange, Inc. | 2.27% | 1,467,474 | NEW |
| MA | Mastercard Inc | 1.95% | 347,692 | TRIMMED (-4.3%) |
| LIN | LINDE PLC | 1.94% | 401,932 | ADDED (+33.6%) |
| AWI | ARMSTRONG WORLD INDUSTRIES INC | 1.64% | 993,344 | ADDED (+7.3%) |
| META | Meta Platforms, Inc. | 1.42% | 192,860 | NEW |
| TMO | THERMO FISHER SCIENTIFIC INC. | 1.36% | 198,227 | NEW |
| VST | Vistra Corp. | 1.34% | 951,011 | ADDED (+96.0%) |
| LAMR | LAMAR ADVERTISING CO/NEW | 1.27% | 867,591 | TRIMMED (-20.4%) |
| DIS | Walt Disney Co | 1.00% | 933,073 | NEW |
Exited this quarter: ACGL, AMAT, CME, CNQ, CRS, EFX, NYT, RIOT, RNR, UBER.
Source: SEC Form 13F filing for the quarter ended Sep 30, 2026, filed Oct 20, 2026. CIK 0001581811. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only and report holdings as of quarter-end; each filing is due within 45 days after quarter-end, so the filing lag above is the gap between quarter-end and this filing’s date, and it varies by when the manager actually filed.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Hypothetical 13F-clone performance — not the fund’s actual returns. The clone holds the long U.S. equity positions disclosed in this manager’s Form 13F filings at their reported weights, rebalanced on filing dates, on dividend-adjusted prices. Full series and the filing-by-filing evidence dossier: 13F-clone profile.
A snapshot at quarter-end, not today’s portfolio: 13F filings arrive up to 45 days late, cover long positions only, and omit cash, shorts, and derivatives. Copying this list also means copying its timing, prices, and position sizes.
Read the original filings at SEC EDGAR.
Not investment advice. Filings are delayed and incomplete.
How we measure: Methodology · Track Record · Q3 2026 13F tracker.
See the same rule applied to every tracked fund, including this one: Follow a Fund — each quarter’s top 5 new and increased positions, bought at the close on the first trading day after the 13F deadline and held for a quarter, scored against SPY.
Compare overlap → Compare your own book against this fund and the other tracked funds.
Markel Group · Track Record: how the signals scored · Compare overlap
One email a week: the week’s new filings and research. Subscribe free
← Edgewood Management · Energy Income Partners →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.